Access to high quality, well characterized, affordable affinity reagents has been deemed a major hurdle in cancer research by representatives of the scientific community. The reagents program within CPTC provides tools, reagents, technologies, and reference materials to allow for peptide and protein analysis for a variety of platforms and applications. The reagents generated within the CPTC program include cancer-related monoclonal antibodies and hybridomas, reference materials, standards kits and MRM peptides. Registration not required.